Medicare Limits Coverage of Controversial Alzheimer’s Drug to Those in Clinical Trials
Medicare Limits Coverage of Controversial Alzheimer’s Drug to Those in Clinical Trials
CNN | Apr 08, 2022
Recent Posts
- Global Down Syndrome Foundation Invests $1.3 Million, Empowers Game-Changing Local Programs
- In Loving Memory: A Tribute to Lorraine Pope
- GLOBAL Recap of 2025 NDSC Annual Convention in Dallas
- Exclusive Interview with Down Syndrome Association of Middle Tennessee Executive Director Alecia Talbott
- Two-time Academy Award Nominee Jeremy Renner to Headline Global Down Syndrome Foundation’s Star-studded Event
Experience our inspirational and groundbreaking videos and photos. Our children and self-advocates are beautiful AND brilliant!
Make sure your local Representatives are on the Congressional Down Syndrome Task Force.